GO:0045116 protein neddylation: Ubiquitin-like Conjugation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045116 (protein neddylation) is the covalent attachment of the ubiquitin-like protein NEDD8 (RUB1) to target proteins, a reversible post-translational modification.
• The best-characterized substrates are cullin proteins, where neddylation activates cullin-RING ligases (CRLs), the largest family of E3 ubiquitin ligases.
• Neddylation proceeds through an enzymatic cascade: NAE1-UBA3 (E1), UBC12/UBE2M or UBE2F (E2), and DCN1 or other E3 ligases.
• Beyond cullins, neddylation regulates non-cullin substrates such as PEPCK1, impacting glucose metabolism and other cellular processes.
• Hyperactivation of neddylation is observed in multiple cancers, making the pathway a therapeutic target; NAE1 inhibitors and DCN1-UBC12 interaction inhibitors are under investigation.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of neddylation enzymes and substrates in health and disease.
Description
Protein neddylation (GO:0045116) is a post-translational modification in which the ubiquitin-like protein NEDD8 (also known as RUB1) is covalently conjugated to lysine residues of target proteins. This process is evolutionarily conserved and plays a central role in regulating protein stability, activity, and subcellular localization. The most extensively studied consequence of neddylation is the activation of cullin-RING ligases (CRLs), which control the degradation of numerous regulatory proteins. However, neddylation also modifies non-cullin substrates, expanding its functional repertoire beyond CRL biology. Dysregulation of neddylation has been linked to cancer, metabolic disorders, and other diseases, making the pathway an attractive target for therapeutic intervention. Small-molecule inhibitors targeting the NEDD8-activating enzyme (NAE1) or the DCN1-UBC12 interaction have shown preclinical efficacy in various cancer models. Understanding the molecular mechanisms, key enzymes, and substrates of neddylation is therefore critical for both basic research and drug development. This article provides a comprehensive overview of GO:0045116, covering its definition, enzymatic cascade, key genes, regulatory mechanisms, disease associations, and the research methods—including CRISPR-based models—used to study this essential pathway.
protein neddylation At A Glance
| GO ID | GO:0045116 |
|---|---|
| GO term | protein neddylation |
| Ontology | biological_process |
| Synonym | RUB1-protein conjugation |
| Definition | Covalent attachment of the ubiquitin-like protein NEDD8 (RUB1) to another protein. |
| Major function | Post-translational modification that regulates protein activity, stability, and interactions, notably activating cullin-RING ligases. |
| Key enzymes | NAE1-UBA3 (E1), UBC12/UBE2M or UBE2F (E2), DCN1 or other E3 ligases. |
| Reversibility | Reversed by deneddylases such as the COP9 signalosome. |
| Substrates | Cullins (CUL1-5), p53, PEPCK1, and other proteins. |
What Is GO:0045116?
Protein neddylation is the covalent attachment of the ubiquitin-like protein NEDD8 (RUB1) to another protein, as defined by the Gene Ontology term GO:0045116. This modification typically occurs on lysine residues of substrate proteins and is mediated by a sequential enzymatic cascade involving E1, E2, and E3 enzymes. Neddylation is reversible, and the removal of NEDD8 is catalyzed by deneddylases such as the COP9 signalosome.
Why Is protein neddylation Important in Cell Biology?
Protein neddylation is essential for numerous cellular processes, including cell cycle progression, DNA damage response, and metabolism, primarily through its role in activating cullin-RING ligases. Dysregulation of neddylation contributes to cancer, metabolic disorders, and other pathologies, and the pathway has emerged as a promising therapeutic target. Understanding neddylation mechanisms and identifying specific substrates are critical for developing targeted therapies and for interpreting disease-associated mutations.
• Regulates the activity of cullin-RING ligases (CRLs), which control the degradation of many key regulatory proteins.
• Modulates non-cullin substrates such as PEPCK1, influencing glucose metabolism.
• Plays a role in cell cycle progression, DNA damage response, and apoptosis.
• Hyperactivated in multiple cancers, including cholangiocarcinoma, and associated with poor prognosis.
• Targeted by small-molecule inhibitors (e.g., MLN4924, gossypol) that block NAE1 or DCN1-UBC12 interaction.
• Involved in immune regulation and tumor-stroma crosstalk.
• Essential for embryonic development; knockout of neddylation enzymes is lethal in model organisms.
• Provides a mechanism for rapid and reversible control of protein function.
• Offers opportunities for CRISPR-based functional genomics to identify novel substrates and regulators.
• Dysregulation linked to neurodegenerative diseases and metabolic syndromes.
What Happens During protein neddylation?
Activation of NEDD8 by the E1 enzyme (NAE1-UBA3)
In simple terms: First, the NEDD8 protein is activated by a two-part enzyme called NAE1-UBA3 in an ATP-dependent manner.
The neddylation cascade begins with the ATP-dependent activation of NEDD8 by the heterodimeric E1 enzyme NAE1-UBA3. This step involves the formation of a high-energy NEDD8-AMP intermediate and subsequent transfer of NEDD8 to a catalytic cysteine residue on UBA3, forming a thioester-linked E1~NEDD8 complex.
Conjugation of NEDD8 to the E2 enzyme (UBC12/UBE2M or UBE2F)
In simple terms: Next, the activated NEDD8 is passed to a carrier enzyme called UBC12 (or UBE2F).
The activated NEDD8 is transferred from the E1 to the active-site cysteine of an E2 conjugating enzyme, primarily UBC12 (UBE2M) or UBE2F. This trans-thioesterification reaction generates a stable E2~NEDD8 thioester intermediate, which is then ready to transfer NEDD8 to a substrate.
Substrate recognition and ligation by E3 enzymes (e.g., DCN1)
In simple terms: An E3 ligase, such as DCN1, brings the E2~NEDD8 complex to the target protein and helps attach NEDD8 to it.
E3 ligases confer substrate specificity. For cullin neddylation, the RING finger protein RBX1 and the DCN1 (defective in cullin neddylation 1) family proteins act as E3s. DCN1 binds to both the E2~NEDD8 complex and the cullin substrate, facilitating the transfer of NEDD8 to a specific lysine residue on the cullin protein. Other E3 ligases may mediate neddylation of non-cullin substrates.
Consequences of neddylation: activation of cullin-RING ligases
In simple terms: Once NEDD8 is attached to a cullin protein, the cullin-RING ligase becomes active and can tag other proteins for degradation.
Neddylation of cullins induces a conformational change that activates the CRL complex, enabling it to ubiquitinate target proteins for proteasomal degradation. This activation is essential for CRL function in processes such as cell cycle regulation and DNA damage response.
Deneddylation and reversibility
In simple terms: The process is reversible: enzymes called deneddylases remove NEDD8 from target proteins.
Deneddylation is catalyzed by the COP9 signalosome (CSN) and other deneddylases, which cleave the isopeptide bond between NEDD8 and the substrate. This reversibility allows dynamic regulation of CRL activity and other neddylation-dependent processes.
Key Genes Involved in GO:0045116 protein neddylation
The following genes and proteins are central to the neddylation pathway, including enzymes, substrates, and regulators.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAE1 | E1 activating enzyme subunit for NEDD8 | Target of inhibitors; knockout causes lethality |
| UBA3 | E1 activating enzyme catalytic subunit | Essential for NEDD8 activation |
| UBC12 (UBE2M) | E2 conjugating enzyme for NEDD8 | Key node for inhibitor development |
| UBE2F | Alternative E2 conjugating enzyme | Neddylation of CUL5 |
| DCN1 (DCUN1D1) | E3 ligase for cullin neddylation | Target for small-molecule inhibitors |
| RBX1 | RING finger protein in CRL complexes | Scaffold for E3 activity |
| CUL1 | Cullin substrate of neddylation | Activates SCF ligase |
| CUL2 | Cullin substrate of neddylation | Activates CRL2 |
| CUL3 | Cullin substrate of neddylation | Activates CRL3 |
| CUL4A | Cullin substrate of neddylation | Activates CRL4A |
| CUL5 | Cullin substrate of neddylation | Activates CRL5 |
| NEDD8 | Ubiquitin-like modifier | Central player in the pathway |
| PEPCK1 (PCK1) | Non-cullin substrate | Regulates glucose metabolism |
| p53 | Non-cullin substrate | Modulates tumor suppressor activity |
| COP9 signalosome (CSN) | Deneddylase complex | Reverses neddylation |
| SENP8 | Deneddylase | Removes NEDD8 from substrates |
| NUB1 | Negative regulator of neddylation | Targets NEDD8 for degradation |
How Is protein neddylation Regulated?
Neddylation is regulated at multiple levels. The pathway is dynamically controlled by the opposing activities of E1/E2/E3 enzymes and deneddylases such as the COP9 signalosome. Additionally, the availability of NEDD8 is regulated by NUB1, which targets NEDD8 for proteasomal degradation. In cancer, neddylation is often hyperactivated, and inhibition of NAE1 or DCN1 has been shown to suppress tumor growth. Metabolic signals can also influence neddylation; for example, PEPCK1 neddylation is modulated by glucose levels. Furthermore, crosstalk with other post-translational modifications, such as ubiquitination and phosphorylation, fine-tunes neddylation substrate specificity.
protein neddylation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAE1 | Cholangiocarcinoma | Knockout or knockdown in cholangiocarcinoma cell lines |
| DCN1 | Cancer (various) | Point mutation to disrupt UBC12 binding |
| PEPCK1 | Metabolic disorders | Knock-in of neddylation-deficient mutant |
| CUL1 | Cancer | Overexpression of neddylation-deficient CUL1 mutant |
| NEDD8 | Cancer, neurodegeneration | Overexpression or knockout in cell models |
Cancer
Neddylation is frequently hyperactivated in cancers, including cholangiocarcinoma, where NAE1-mediated hyper-neddylation promotes tumor growth and stroma crosstalk. Targeting neddylation with inhibitors such as MLN4924 (pevonedistat) or gossypol has shown antitumor activity in preclinical models. DCN1-UBC12 interaction inhibitors also block CRL activation and suppress cancer cell proliferation. These findings highlight neddylation as a promising therapeutic target in oncology.
Metabolic disorders
Neddylation of PEPCK1, a key enzyme in gluconeogenesis, controls glucose metabolism. Dysregulation of this modification may contribute to metabolic diseases such as diabetes. This links neddylation directly to metabolic homeostasis and suggests that targeting this pathway could have metabolic consequences.
Other diseases
Dysregulation of neddylation has been implicated in neurodegenerative diseases and developmental disorders, although the exact mechanisms are still being elucidated. The essential role of neddylation in cell cycle and DNA damage response suggests that its perturbation could affect a broad range of pathological conditions.
From protein neddylation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NAE1 affect tumor growth? | NAE1 knockout cell lines and xenografts |
| What is the role of DCN1-UBC12 interaction in CRL activation? | DCN1 point mutants that cannot bind UBC12 |
| How does PEPCK1 neddylation regulate glucose metabolism? | PEPCK1 knock-in mice with neddylation-site mutation |
| What are the substrates of neddylation? | Tagged knock-in of NEDD8 for proteomic identification |
| Does overexpression of NEDD8 promote cancer? | NEDD8 overexpression cell lines and mouse models |
| Can CRISPR screening identify regulators of neddylation? | Genome-wide CRISPR knockout library screening |
How to Study the protein neddylation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot with anti-NEDD8 | Global neddylation levels | Assessing pathway activity |
| Immunoprecipitation | Neddylation of specific proteins | Validating substrates |
| Mass spectrometry | Identification of neddylated proteins | Substrate discovery |
| CRISPR knockout | Loss-of-function phenotypes | Gene function studies |
| CRISPR knock-in | Tagged or mutant protein expression | Tracking neddylation in vivo |
| CRISPR point mutation | Specific residue function | Dissecting catalytic mechanisms |
| CRISPR library screening | Genome-wide modifiers | Identifying regulators |
| Small-molecule inhibitors | Pathway inhibition | Therapeutic testing |
Proteomic approaches for substrate identification
Mass spectrometry-based proteomics, often combined with tagged NEDD8 (e.g., His-tagged NEDD8) and affinity purification, enables the identification of neddylated proteins. This approach has expanded the repertoire of known substrates beyond cullins.
Western blotting and immunoprecipitation
Western blotting with anti-NEDD8 antibodies can detect global neddylation levels, while immunoprecipitation of specific proteins followed by anti-NEDD8 blotting confirms substrate modification. These methods are standard for validating neddylation events.
CRISPR-based functional genomics
CRISPR knockout, knock-in, and point mutation models allow precise dissection of neddylation enzyme and substrate functions. Genome-wide CRISPR screens can identify genes that modulate neddylation or confer sensitivity to neddylation inhibitors.
Small-molecule inhibitor studies
Inhibitors such as MLN4924 (targeting NAE1) and DCN1-UBC12 interaction inhibitors are used to probe pathway function and as potential therapeutics. These compounds can be combined with genetic models to assess synergy and resistance mechanisms.
How CRISPR Can Be Used to Study GO:0045116 protein neddylation
Knockout
CRISPR knockout of neddylation enzymes (e.g., NAE1, UBC12, DCN1) can reveal essential functions and validate therapeutic targets. However, complete knockout of core enzymes may be lethal, requiring inducible systems.
Point Mutation
Point mutations that abrogate catalytic activity or substrate binding (e.g., DCN1 mutants unable to bind UBC12) allow precise dissection of protein-protein interactions and enzymatic steps.
Knock-in
Knock-in of tagged NEDD8 or mutant substrates (e.g., neddylation-deficient PEPCK1) enables tracking of neddylation dynamics and functional consequences in physiological contexts.
Overexpression
Overexpression of NEDD8 or neddylation enzymes can model hyper-neddylation states observed in cancer and test oncogenic potential. Conversely, overexpression of dominant-negative mutants can inhibit the pathway.
How EDITGENE Supports protein neddylation Research
Researchers studying protein neddylation-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, substrate modification, or disease progression. Precise genetic models are essential to move from correlation to causation.
Contact EDITGENE today to design your custom CRISPR model for protein neddylation research.
Frequently Asked Questions About protein neddylation
What is protein neddylation?
Protein neddylation (GO:0045116) is the covalent attachment of the ubiquitin-like protein NEDD8 to target proteins, regulating their activity and stability.
What genes are involved in protein neddylation?
Key genes include NAE1, UBA3, UBC12 (UBE2M), UBE2F, DCN1, RBX1, and cullin genes (CUL1-5), as well as NEDD8 itself.
What is the role of neddylation in cancer?
Hyperactivation of neddylation promotes cancer growth, and inhibitors targeting NAE1 or DCN1 show antitumor activity in preclinical models.
How is neddylation regulated?
Neddylation is regulated by the opposing activities of E1/E2/E3 enzymes and deneddylases like the COP9 signalosome, as well as by NEDD8 availability.
What are the substrates of neddylation?
Cullin proteins are the best-characterized substrates; non-cullin substrates include p53 and PEPCK1.
What diseases are associated with neddylation?
Neddylation is linked to cancer, metabolic disorders, and neurodegenerative diseases.
How can CRISPR be used to study neddylation?
CRISPR knockout, knock-in, point mutation, and overexpression models allow precise functional dissection of neddylation genes and substrates.
What are the current therapeutic strategies targeting neddylation?
Small-molecule inhibitors such as MLN4924 (pevonedistat) and DCN1-UBC12 interaction inhibitors are under development.
What is the difference between neddylation and ubiquitination?
Both are ubiquitin-like modifications, but neddylation uses NEDD8 and its own E1, E2, and E3 enzymes, and it primarily activates CRLs rather than targeting proteins for degradation directly.
Can neddylation be reversed?
Yes, deneddylases such as the COP9 signalosome remove NEDD8 from substrates, making the modification reversible.
Conclusion
Protein neddylation (GO:0045116) is a critical post-translational modification that regulates diverse cellular processes through the conjugation of NEDD8 to target proteins, most notably cullins. Its dysregulation is implicated in cancer and metabolic disorders, and the pathway is a promising therapeutic target. Continued research using advanced CRISPR models and proteomic approaches will further elucidate its mechanisms and identify new opportunities for intervention.
References
- 1. Enchev RI et al.. 2015. Protein neddylation: beyond cullin-RING ligases.. Nat Rev Mol Cell Biol 16(1):30-44 PMID: 25531226
- 2. Zhang S et al.. 2024. Protein neddylation and its role in health and diseases.. Signal Transduct Target Ther 9(1):85 PMID: 38575611
- 3. Zhou L et al.. 2020. Targeting Protein Neddylation for Cancer Therapy.. Adv Exp Med Biol 1217:297-315 PMID: 31898235
- 4. Zhou H et al.. 2020. Targeting DCN1-UBC12 Protein-Protein Interaction for Regulation of Neddylation Pathway.. Adv Exp Med Biol 1217:349-362 PMID: 31898237
- 5. Olaizola P et al.. 2022. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.. J Hepatol 77(1):177-190 PMID: 35217064
- 6. Gonzalez-Rellan MJ et al.. 2023. Neddylation of phosphoenolpyruvate carboxykinase 1 controls glucose metabolism.. Cell Metab 35(9):1630-1645.e5 PMID: 37541251
- 7. Zhang S et al.. 2026. Protein neddylation as a therapeutic target: challenges and opportunities.. J Clin Invest 136(15) PMID: 42544581
- 8. Yu Q et al.. 2021. Targeting Protein Neddylation to Inactivate Cullin-RING Ligases by Gossypol: A Lucky Hit or a New Start?. Drug Des Devel Ther 15:1-8 PMID: 33442232
